Immunity Bio
Biotechnology, 3530 John Hopkins Ct, San Diego, California, 92121, United States, 501-1000 Employees
Phone Number: 31********
Who is IMMUNITYBIO
ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patients natural immune system, potentially enabling i...
Read More
-
Headquarters: 3530 John Hopkins Ct, San Diego, California, 92121, United States
-
Employees: 501-1000
-
Revenue: $1 Million to $5 Million
-
CEO:
Richard Adcock
Email
Phone
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from IMMUNITYBIO
ImmunityBio Org Chart and Mapping
Similar Companies to ImmunityBio
NantWorks
-
1001-5000
-
$ 10 Million to 25 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding ImmunityBio
Answer: ImmunityBio's headquarters are located at 3530 John Hopkins Ct, San Diego, California, 92121, United States
Answer: ImmunityBio's phone number is 31********
Answer: ImmunityBio's official website is https://immunitybio.com
Answer: ImmunityBio's revenue is $1 Million to $5 Million
Answer: ImmunityBio's SIC: 2836
Answer: ImmunityBio's NAICS: 541714
Answer: ImmunityBio has 501-1000 employees
Answer: ImmunityBio is in Biotechnology
Answer: ImmunityBio top competitors include: NantWorks
Answer: ImmunityBio contact info: Phone number: 31******** Website: https://immunitybio.com
Answer: ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patients natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells. The activation of the innate immune system is key to the development of immunological memory. Over the last two decades, our founder and Executive Chairman Dr. Patrick Soon-Shiong has investigated mechanisms to activate the immune system to attack tumors that can otherwise evade and escape the bodys defense mechanisms. After inventing the worlds first protein nanoparticle drug, Abraxane, Dr. Soon-Shiong turned his focus to the next generation of immunotherapies. ImmunityBio was founded in 2014 to create innovative immunotherapies that address serious unmet needs in oncology and infectious diseases. "At ImmunityBio, we envision a day when we no longer fear cancer but are able to conquer it, thanks to the biological wonder that is the human immune system. Our scientists are working to develop remarkable new therapies that harness that inherent power by amplifying both branches of the immune system, attacking cancerous or infected cells today while building immunological memory for tomorrow. The goal: to reprogram the patients immune system and treat the host rather than just the disease." -Dr. Patrick Soon-Shiong, Executive Chairman
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month